Showing results (341-350 of 548) with videos related to

Sort By:
Pageof 55
The Journal of Clinical Investigation|October 1, 1993
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primatesS R Hanson, J H Griffin, L A Harker, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Conductive microgel annealed scaffolds enhance myogenic potential of myoblastic cellsAlena Casella, Jeremy Lowen, Nathan Shimamoto, et al.
Pharmaceutical Research|March 11, 2016
Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe BleedingAndrew J Gale, Vikas Bhat, Jean-Luc Pellequer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Total chemical synthesis of enzymatically active human type II secretory phospholipase A2T M Hackeng, C M Mounier, C Bon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 2016
Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier StabilizationRanjeet K Sinha, Xia V Yang, José A Fernández, et al.
Biomaterials|January 1, 2021
Hydrogel mechanics are a key driver of bone formation by mesenchymal stromal cell spheroidsJacklyn Whitehead, Katherine H Griffin, Marissa Gionet-Gonzales, et al.
Advanced Healthcare Materials|September 6, 2021
Sulfated Alginate Hydrogels Prolong the Therapeutic Potential of MSC Spheroids by Sequestering the SecretomeMarissa Gionet-Gonzales, Alena Casella, Daphne Diloretto, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Full-length plasma skeletal muscle myosin isoform deficiency is associated with coagulopathy in acutely injured patientsJulia R Coleman, Hiroshi Deguchi, Taichi K Deguchi, et al.
Nature Medicine|November 2, 2004
Tissue plasminogen activator neurovascular toxicity is controlled by activated protein CDong Liu, Tong Cheng, Huang Guo, et al.
Blood|June 1, 1981
Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agentsL A Miles, J P Burnier, M S Verlander, et al.
Pageof 55